Oxycodone

Label Mnemonic:	OXYCU
Epic code:	LAB7386
Downtime form:	Doctor/Provider Orders - Pathology Core and Specialty Care Nursery

Chemistry
6240 RCP
356-3527

Specimen(s):

Urine Screen, Random

Collection Medium:

Clear top tube

Alternate Collection Media:

Urine (Random)-BD Vacutainer^®, no additive yellow top

Minimum:

5 mL random urine

Rejection Criteria:

Test cannot be added to a urine sample previously utilized for urinalysis testing (LAB1160, LAB1164, LAB8379).

Testing Schedule:

24 hrs/day, 7 days a week, including holidays.

Turn Around Time:

1 hour (upon receipt in laboratory)

Reference Range:

None

Interpretive Data:

Drug of abuse screening tests are to be used for medical purposes only and not for non-medical purposes (e.g., employee, competitive athlete, or forensic testing).

Comments:

Screen includes oxycodone and oxymorphone only.  For full drugs 
of abuse-urine panel, see "Drugs of Abuse Screen".

If quantitative confirmation is needed for oxycodone or oxymorphone, call the 
Laboratory at 356-3527. Allow up to seven days for confirmatory 
results. 

Quantitative confirmation is at an additional charge.

Approximate cut-off concentrations (ng/mL)*
-----------------------------------------
Oxycodone          300
Oxymorphone        291

*Assay does not cross-react with other opiates such as buprenorphine, 
codeine, heroin, hydrocodone, hydromorphone, and morphine, or with 
synthetic opioids such as fentanyl, meperidine, methadone, or 
propoxyphene.

References:
Belson MG, Simon HK, Sullivan K, Geller RJ.  The Utility of 
Toxicologic Analysis in Children with Suspected Ingestion.  Pediatr 
Emerg Care 1999;15:383-387.

Bast RP, Helmer SD, Henderson SR, Rogers MA, Shapiro WM, Smith RS.  
Limited Utility of Routine Drug Screening in Trauma Patients.  South 
Med J 2000;93:397-399.

Hammett-Stabler CA, Pesce AJ, Cannon DJ.  Urine Drug Screening in the 
Medical Setting.  Clinica Chimica Acta 2002;315:125-135.

Schiller MJ, Shumway M, Batki SL.  Utility of Routine Drug Screening 
in a Psychiatric Emergency Setting.  Psychiatric Services 2000;51:474-
478.

Sugarman JM, Rodgers GC, Paul RI.  Utility of Toxicology Screening in 
a Pediatric Emergency Department.  Pediatric Emergency Care.  
Pediatric Emergency Care 1997;13(3):194-197.

Test Limitations:

There is the possibility that other substances and/or factors may interfere with the test and cause erroneous results (e.g., technical or procedural errors). Call the lab at 319-356-3527 for additional information.

Methodology:

Enzyme Immunoassay (EIA)

CPT Code:

80365

See also:
Drugs of Abuse, Urine
Drugs of Abuse, Urine + Confirm